GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity
{{output}}
Inflammatory bowel disease remains a chronic condition in which a substantial proportion of patients fail to achieve durable clinical remission despite advances in therapy. Although the treatment landscape has expanded to include biologics and small-molecule a... ...
